Korean Market
OWNR
Cell Bio Human Tech
★

CEO Kwon-seon Lee Increases Stake to 34.65% via Open Market Purchases

 
OWNR
Cell Bio Human Tech
★

CEO Kwon-seon Lee acquires additional 7,053 shares via open market purchase (avg. 6,978 won)

 
EXCH
Cell Bio Human Tech
★

Correction Announcement for Acquisition of Tangible Assets - Factory Purchase of 5.4 Billion KRW, Date Change

 
PERI
Cell Bio Human Tech
★★

Cell Bio Human Tech Q1 2026 Consolidated Revenue 12.7B KRW… Up 54% YoY

 
EXCH
Cell Bio Human Tech
★

Completion of Small Capital Reduction, 3,688 Shares Reduced